375 related articles for article (PubMed ID: 24176990)
1. The distribution of COPD in UK general practice using the new GOLD classification.
Haughney J; Gruffydd-Jones K; Roberts J; Lee AJ; Hardwell A; McGarvey L
Eur Respir J; 2014 Apr; 43(4):993-1002. PubMed ID: 24176990
[TBL] [Abstract][Full Text] [Related]
2. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
[TBL] [Abstract][Full Text] [Related]
4. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations.
Jones PW; Nadeau G; Small M; Adamek L
Respir Med; 2014 Jan; 108(1):129-35. PubMed ID: 24041746
[TBL] [Abstract][Full Text] [Related]
6. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD).
Rebordosa C; Plana E; Aguado J; Thomas S; García-Gil E; Perez-Gutthann S; Castellsague J
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):126-133. PubMed ID: 29740896
[TBL] [Abstract][Full Text] [Related]
7. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.
Soriano JB; Lamprecht B; Ramírez AS; Martinez-Camblor P; Kaiser B; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Marin JM; Puhan MA; Sobradillo P; Lange P; Sternberg AL; Garcia-Aymerich J; Turner AM; Han MK; Langhammer A; Leivseth L; Bakke P; Johannessen A; Roche N; Sin DD
Lancet Respir Med; 2015 Jun; 3(6):443-50. PubMed ID: 25995071
[TBL] [Abstract][Full Text] [Related]
8. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a claims-based prediction model for COPD severity.
Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
[TBL] [Abstract][Full Text] [Related]
10. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
[TBL] [Abstract][Full Text] [Related]
11. Chronic obstructive pulmonary disease in Poland: distribution of patients according to the new GOLD 2011 classification. Cross-sectional survey.
Wesołowski S; Boros PW; Dębowski T
Pneumonol Alergol Pol; 2014; 82(6):511-7. PubMed ID: 25339561
[TBL] [Abstract][Full Text] [Related]
12. The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.
Sundh J; Johansson G; Larsson K; Lindén A; Löfdahl CG; Sandström T; Janson C
Int J Chron Obstruct Pulmon Dis; 2015; 10():2327-34. PubMed ID: 26604732
[TBL] [Abstract][Full Text] [Related]
13. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
Mittal R; Chhabra SK
COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
[TBL] [Abstract][Full Text] [Related]
14. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
15. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.
Menezes AM; Wehrmeister FC; Perez-Padilla R; Viana KP; Soares C; Müllerova H; Valdivia G; Jardim JR; Montes de Oca M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1491-1501. PubMed ID: 28553101
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK.
Rothnie KJ; Numbere B; Gelwicks S; Lu Y; Sharma R; Compton C; Ismaila AS; Quint JK
Int J Chron Obstruct Pulmon Dis; 2023; 18():2673-2685. PubMed ID: 38022832
[TBL] [Abstract][Full Text] [Related]
17. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.
Högman M; Sulku J; Ställberg B; Janson C; Bröms K; Hedenström H; Lisspers K; Malinovschi A
Int J Chron Obstruct Pulmon Dis; 2018; 13():165-173. PubMed ID: 29379281
[TBL] [Abstract][Full Text] [Related]
18. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
Echave-Sustaeta JM; Comeche Casanova L; Cosio BG; Soler-Cataluña JJ; Garcia-Lujan R; Ribera X
Int J Chron Obstruct Pulmon Dis; 2014; 9():1307-14. PubMed ID: 25429213
[TBL] [Abstract][Full Text] [Related]
20. Stratification of patients with COPD according to the 2011 GOLD report.
Grzelewska-Rzymowska I; Patora-Mikołajczyk J; Górski P
Pneumonol Alergol Pol; 2014; 82(5):415-21. PubMed ID: 25133809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
